SLU Study: Immune Dysfunction Increases Cancer Risk in Obese Populations
11/14/2024
ST. LOUIS —Researchers at Saint Louis University’s School of Medicine say T-cell dysfunction is leading to an increased risk of cancer in obese populations.
T cells are white blood cells called lymphocytes essential to your immune system in the fight against infections and cancer. Ryan Teague, Ph.D., professor of molecular microbiology and immunology at SLU, and his team are exploring why obesity impacts T-cell dysfunction and compromises immune surveillance, or the body’s ability to survey malignant cells and clear them before they become tumors.
Ryan Teague, Ph.D., left, and Alex Piening, an M.D./Ph.D. graduate student at SLU, work in the lab in Doisy Research Center on October 21, 2024. Photo by Sarah Conroy.
The study, which was led by Teague and co-authored by Alex Piening, an M.D./Ph.D. graduate student at SLU, was recently published in Nature Communications, found that T-cell dysfunction linked to obesity prevented T cells from detecting tumor cells, placing obese mice at higher risk of developing tumors when exposed to a carcinogen. Teague and his team are now trying to uncover the exact mechanism underlying the metabolic dysfunctions associated with obesity that directly impact T-cell function.
Ongoing projects in Teague’s lab at SLU are designed to identify barriers to successful cancer immunotherapy and develop strategies to overcome these barriers for improved patient outcomes. Teague and his team investigate how obesity impacts the efficacy of immunotherapies.
"Immunotherapy boosts a patient's immune system by targeting T cells and reinvigorating them. Paradoxically, immunotherapy is often more successful in patients with obesity, where the immune system isn’t functioning quite as well," Teague said. "Our research explains this paradox by showing that in the setting of obesity, developing tumors are only required to escape a weakened immune system. Such outgrown tumors are not well adapted to evade the reinvigorated T cells elicited during immunotherapy, and thus, are more easily destroyed."
Teague said single-cell RNA sequencing played a critical role in the study’s findings, which allowed scientists to learn what’s happening inside individual immune cells within tumors.
"We learned that the dysfunction in these T cells lies in their inability to kill tumors. Those genes were not being turned on. It also lies in their inability to acquire the metabolic functions needed to sustain anti-tumor activity," Teague said.
Thanks to SLU’s investment in single-cell RNA sequencing technology, the Department of Molecular Microbiology and Immunology has leveraged this new approach to advance its work studying cancer and the immune system, bringing us closer to new cures.
Other authors include Kelly D. Pyles, Kyle S. McCommis, Ph.D., Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine; Emily Ebert, Carter Gottlieb, Niloufar Khojandi, Lindsey M. Kuehm, Stella G. Hoft, Richard J. DiPaolo, Ph.D., Stephen T. Ferris, Ph.D., Elise Alspach, Ph.D., Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine.
Latest Newslink
- Watch What You Eat: NFL Game Advertisements Promote Foods High in Fat, SodiumResearch from Saint Louis University and the University of Nevada, Reno School of Medicine finds that some of the most-watched ads promote the worst food options for adults with chronic health conditions.
- SLU Theatre and Dance Faculty Nominated for Theatre Circle AwardsSaint Louis University Theatre and Dance faculty will be well represented at the 2025 St. Louis Theatre Circle Awards. Full-time SLU faculty members Gary Wayne Barker, professor of theatre; Nancy Bell, professor of theatre; Lucy Cashion, associate professor of theatre; and Denisse Chavez, assistant professor of visual and performing arts, all received nominations for their work with various productions. Adjust faculty member Joel Moses, theater, was also recognized by the St. Louis Theater Circle.
- Achieves Prestigious R1 Status, Joining Elite Group of U.S. Research UniversitiesR1 designation is the highest classification that universities can attain for research activity. SLU’s rise to R1 is the result of a decade-long, institution-wide effort to become a national exemplar for educational and research excellence. Since 2014, the University has focused on creating a robust research environment that fosters collaboration across disciplines and offers new opportunities for faculty and students to explore today’s most urgent challenges.
- Six SLU Students Advance to Semifinalist Stage for Fulbright GrantsSaint Louis University's Office of Competitive Fellowships and Scholarships has announced that six SLU students have been selected as semifinalists for the prestigious Fulbright U.S. Student Program. Fulbright decisions are updated regularly, and applicants will be notified in the spring whether they have been selected as finalists to receive the award.
- Tickets to See Colson Whitehead Receive 2025 St. Louis Literary Award Go on Sale on February 7Tickets for the St. Louis Literary Award ceremony honoring Pulitzer Prize-winning author Colson Whitehead will go on sale Friday, Feb. 7, at 10 a.m. Whitehead will receive the award on April 9 at the Sheldon Concert Hall. Tickets for the 2025 St. Louis Literary Award event are $15 and available through Metrotix.
- Second SLU Golf and Give Challenge Set for February 25-26The Saint Louis University community is invited to chip in and stock the Billiken Bounty food pantry by playing miniature golf holes created by SLU students. The innovation challenge is led by SLU's School of Science and Engineering and Chaifetz Center for Entrepreneurship.